LRRK2 is the most common cause of genetic Parkinson's disease, making it one of the most prominent targets for treatment. And while the protein contributes to Parkinson’s disease in some people, it actually protects against conditions like Crohn’s disease and certain cancers. Dr. Valina Dawson of Johns Hopkins explains the latest in Parkinson's research. #ParkinsonsDisease #JohnsHopkins
Learn more about Parkinson’s disease and movement disorders treatment at Johns Hopkins: www.hopkinsmedicine.org/neuro...
Негізгі бет Ғылым және технология Genetic Mutations in Parkinson's Disease | 2019 Udall Center Research Symposium
Пікірлер: 9